TIAA CREF Investment Management’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-165,731
Closed -$4.74M 3036
2018
Q4
$4.74M Sell
165,731
-6,323
-4% -$180K ﹤0.01% 1420
2018
Q3
$4.8M Sell
172,054
-11,980
-7% -$337K ﹤0.01% 1595
2018
Q2
$5.13M Sell
184,034
-53,960
-23% -$1.45M ﹤0.01% 1579
2018
Q1
$5.92M Buy
237,994
+1,714
+0.7% +$41.7K ﹤0.01% 1451
2017
Q4
$5.72M Sell
236,280
-14,375
-6% -$379K ﹤0.01% 1527
2017
Q3
$6.92M Buy
250,655
+34,867
+16% +$930K ﹤0.01% 1418
2017
Q2
$5.41M Buy
215,788
+2,129
+1% +$52.7K ﹤0.01% 1553
2017
Q1
$5.73M Sell
213,659
-9,626
-4% -$266K ﹤0.01% 1506
2016
Q4
$5.85M Sell
223,285
-11,587
-5% -$287K ﹤0.01% 1494
2016
Q3
$5.87K Sell
234,872
-4,276
-2% -$99.7K ﹤0.01% 1497
2016
Q2
$5.18M Sell
239,148
-1,715
-0.7% -$30.6K ﹤0.01% 1512
2016
Q1
$3.61M Sell
240,863
-4,464
-2% -$74.8K ﹤0.01% 1722
2015
Q4
$5.38M Buy
245,327
+14,935
+6% +$278K ﹤0.01% 1509
2015
Q3
$3.63M Sell
230,392
-9,019
-4% -$145K ﹤0.01% 1755
2015
Q2
$3.42M Buy
239,411
+26,746
+13% +$453K ﹤0.01% 1951
2015
Q1
$3.68M Sell
212,665
-6,856
-3% -$121K ﹤0.01% 1846
2014
Q4
$3.94M Sell
219,521
-11,684
-5% -$188K ﹤0.01% 1794
2014
Q3
$3.04M Sell
231,205
-3,297
-1% -$44.4K ﹤0.01% 1945
2014
Q2
$3.37M Buy
234,502
+3,423
+1% +$44.7K ﹤0.01% 1961
2014
Q1
$2.94M Sell
231,079
-12,388
-5% -$162K ﹤0.01% 2003
2013
Q4
$2.44M Sell
243,467
-736
-0.3% -$8.35K ﹤0.01% 2129
2013
Q3
$3.21M Sell
244,203
-865
-0.4% -$11.3K ﹤0.01% 1909
2013
Q2
$3.5M Buy
+245,068
New +$3.08M ﹤0.01% 1778

Other funds holding NXTM

TIAA CREF Investment Management's NXTM Position: Q1 2019 in Review

TIAA CREF Investment Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 165,731 shares — an estimated $4.74M sold.

TIAA CREF Investment Management first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $6.92M in Q3 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • TIAA CREF Investment Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • TIAA CREF Investment Management sold 165,731 NxStage Medical Inc. shares in Q1 2019, an estimated $4.74M.
  • TIAA CREF Investment Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • TIAA CREF Investment Management's NxStage Medical Inc. position peaked at $6.92M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.